Versartis

Biopharma company developing long-acting therapeutic proteins for the treatment of endocrine disorders

placeRedwood City, California, United States calendar_todayFounded 2008 groups5 employees language versartis.com

Registered entities

Investor mix

8 investors on record; lead investors include Aisling Capital, Sofinnova Investments.

Investor typeCountShare
Venture capital675%
Private equity113%
Other / undisclosed113%
Coming soon